Alexion Pharmaceuticals (ALXN) PT Raised to $163 at SVB Leerink
July 31, 2020 6:41 AM
SVB Leerink analyst Geoffrey Porges raised the price target on Alexion Pharmaceuticals (NASDAQ: ALXN) to $163.00 (from $159.00) while maintaining a Outperform rating.
